2018
DOI: 10.1038/s41467-018-03119-w
|View full text |Cite
|
Sign up to set email alerts
|

Polyrotaxane-based supramolecular theranostics

Abstract: The development of smart theranostic systems with favourable biocompatibility, high loading efficiency, excellent circulation stability, potent anti-tumour activity, and multimodal diagnostic functionalities is of importance for future clinical application. The premature burst release and poor degradation kinetics indicative of polymer-based nanomedicines remain the major obstacles for clinical translation. Herein we prepare theranostic shell-crosslinked nanoparticles (SCNPs) using a β-cyclodextrin-based polyr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
128
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 206 publications
(132 citation statements)
references
References 35 publications
1
128
0
Order By: Relevance
“…Organic molecular PA contrast agents, including porphyrin, melanin, cyanine‐based dyes, and perylene‐diimide (PDI), have been widely applied in PA imaging due to their excellent biodegradability and biocompatibility. In 2011, Zheng and co‐workers developed porphysomes by combining porphyrin with phospholipids and integrating porphyrin–phospholipids into nanovesicles via a self‐assembly approach .…”
Section: Organic Contrast Agentsmentioning
confidence: 99%
“…Organic molecular PA contrast agents, including porphyrin, melanin, cyanine‐based dyes, and perylene‐diimide (PDI), have been widely applied in PA imaging due to their excellent biodegradability and biocompatibility. In 2011, Zheng and co‐workers developed porphysomes by combining porphyrin with phospholipids and integrating porphyrin–phospholipids into nanovesicles via a self‐assembly approach .…”
Section: Organic Contrast Agentsmentioning
confidence: 99%
“…Folate-terminated polyrotaxanes were developed by modifying PEG chains and target mitochondrium [18]. Polyrotaxane-based theranostics were also fabricated with excellent anti-tumor performance [19]. Cationic cyclodextrin polyrotaxanes can be also used for the cellular delivery of polynucleotides [20] and genes [21].…”
Section: Cyclodextrin Associates Polypseudorotaxanes and Polyrotaxanesmentioning
confidence: 99%
“…19 The synthesis, characterization and mechanism of threading of PRs and PPRs based on CDs and different polymers, have been extensively reviewed in the literature, 2,3,20 as well as their potential applications in biomedicine, particularly in drug delivery, or biomaterials, such as hydrogels and scaffolds in tissue engineering. 9,10,[21][22][23] The first PPR based on CDs was reported by Harada in 1990, 24 and obtained from the complexation of PEG and α-CD in water, with a composition of 2 ethylene oxide (EO) units per CD. Harada also established that the binding is very selective, depending on the type of CD and monomer: 1,24,25 α-CD only forms stable inclusion complexes with PEG, while the threading does not occur with polypropylene glycol (PPG); instead, β-and γ-CD form PPRs with PPG but not with PEG.…”
Section: Introductionmentioning
confidence: 99%